Product Reports Resources Pricing Login Book a demo

CytomX Therapeutics

Biotech & Life Sciences · South San Francisco, United States · Founded 2008 · IPO 2015

Early-stage biotechnology company developing probodies, proteolytically-activated antibodies

Valuation $331M
Revenue $36M

Talent graph

CytomX Therapeutics's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on CytomX Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 7 investors entered at this stage
Mike Panesis
Tech Coast Angels
Pfizer Ventures
Canaan
Third Rock Ventures
Roche Venture Fund
BVF Partners

Global footprint

Where CytomX Therapeutics has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
16K monthly visits
across markets
🇺🇸 United States90%
🇮🇳 India6.9%
🇯🇵 Japan3.8%
🇬🇧 United Kingdom1.9%
🇭🇰 Hong Kong0%
Top 5 markets shown

Patent intelligence

$156M patent portfolio · 80 active families

Estimated portfolio value
$156M
47.0% of market cap · 2.1× smaller than top peer MorphoSys ($321M)
80 active patent families
Where CytomX Therapeutics innovates Anti antibodyAntibodyAntiendomysial antibodiesBiochemistryCell biology

Where CytomX Therapeutics concentrates vs peers

Each axis is a top-10 topic across CytomX Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about CytomX Therapeutics

An AI-synthesized read of the highest-engagement posts about CytomX Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CytomX Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.